AR030912A1 - Uso de derivados monosacaridos triciclicos y sus sales para preparar un medicamento para prevenir o tratar la neurodegeneracion inducida por isquemia, derivados monosacaridos triciclicos y sales y composiciones farmaceuticas que los comprenden - Google Patents
Uso de derivados monosacaridos triciclicos y sus sales para preparar un medicamento para prevenir o tratar la neurodegeneracion inducida por isquemia, derivados monosacaridos triciclicos y sales y composiciones farmaceuticas que los comprendenInfo
- Publication number
- AR030912A1 AR030912A1 ARP000103837A ARP000103837A AR030912A1 AR 030912 A1 AR030912 A1 AR 030912A1 AR P000103837 A ARP000103837 A AR P000103837A AR P000103837 A ARP000103837 A AR P000103837A AR 030912 A1 AR030912 A1 AR 030912A1
- Authority
- AR
- Argentina
- Prior art keywords
- monosacaridate
- tricycle
- derivatives
- pharmaceutical compositions
- neurodegeneration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Los compuestos anticonvulsivos de formula general (1): en donde X, R1, R2, R3, R4, R5, y R6 son como se definen en la memoria, son utiles para prevenir o tratar la neurodegeneracion inducida por isquemia, tal como ocurre durante y después de un derrame cerebral, trauma cefálico, lesion de la médula espinal, ataque cardíaco no fatal, o procedimientos quirurgicos mayores. Y composiciones farmacéuticas que los contienen así como el uso de los mismos para preparar medicamentos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14561899P | 1999-07-26 | 1999-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR030912A1 true AR030912A1 (es) | 2003-09-03 |
Family
ID=22513879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000103837A AR030912A1 (es) | 1999-07-26 | 2000-07-25 | Uso de derivados monosacaridos triciclicos y sus sales para preparar un medicamento para prevenir o tratar la neurodegeneracion inducida por isquemia, derivados monosacaridos triciclicos y sales y composiciones farmaceuticas que los comprenden |
Country Status (15)
Country | Link |
---|---|
US (1) | US6495523B1 (es) |
EP (1) | EP1204669B1 (es) |
JP (1) | JP2003505465A (es) |
AR (1) | AR030912A1 (es) |
AT (1) | ATE309261T1 (es) |
AU (1) | AU775296B2 (es) |
CA (1) | CA2380208A1 (es) |
CY (1) | CY1105359T1 (es) |
DE (1) | DE60023910T2 (es) |
DK (1) | DK1204669T3 (es) |
ES (1) | ES2252033T3 (es) |
MX (1) | MXPA02000924A (es) |
NZ (1) | NZ516783A (es) |
TW (1) | TW559558B (es) |
WO (1) | WO2001007453A1 (es) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242942A (en) | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
US5258402A (en) | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
NZ277725A (en) | 1993-12-23 | 1998-04-27 | Ortho Pharma Corp | Pseudofructopyranose sulphamate derivatives, preparation and pharmaceutical compositions thereof |
US5498629A (en) * | 1993-12-23 | 1996-03-12 | Ortho Pharmaceutical Corporation | Anticonvulsant pseudofructopyranose sulfamates |
WO1998000124A1 (en) * | 1996-06-28 | 1998-01-08 | Ortho Pharmaceutical Corporation | Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration |
WO2000050020A2 (en) * | 1999-02-24 | 2000-08-31 | University Of Cincinnati | Use of sulfamate derivatives for treating impulse control disorders |
-
2000
- 2000-07-20 US US09/620,510 patent/US6495523B1/en not_active Expired - Fee Related
- 2000-07-20 CA CA002380208A patent/CA2380208A1/en not_active Abandoned
- 2000-07-20 WO PCT/US2000/019800 patent/WO2001007453A1/en active IP Right Grant
- 2000-07-20 DE DE60023910T patent/DE60023910T2/de not_active Expired - Fee Related
- 2000-07-20 DK DK00950475T patent/DK1204669T3/da active
- 2000-07-20 EP EP00950475A patent/EP1204669B1/en not_active Expired - Lifetime
- 2000-07-20 MX MXPA02000924A patent/MXPA02000924A/es active IP Right Grant
- 2000-07-20 JP JP2001512537A patent/JP2003505465A/ja active Pending
- 2000-07-20 ES ES00950475T patent/ES2252033T3/es not_active Expired - Lifetime
- 2000-07-20 AT AT00950475T patent/ATE309261T1/de not_active IP Right Cessation
- 2000-07-20 NZ NZ516783A patent/NZ516783A/en unknown
- 2000-07-20 AU AU63577/00A patent/AU775296B2/en not_active Ceased
- 2000-07-25 AR ARP000103837A patent/AR030912A1/es not_active Application Discontinuation
- 2000-09-21 TW TW089114868A patent/TW559558B/zh not_active IP Right Cessation
-
2006
- 2006-01-11 CY CY20061100034T patent/CY1105359T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE60023910D1 (de) | 2005-12-15 |
AU6357700A (en) | 2001-02-13 |
ATE309261T1 (de) | 2005-11-15 |
MXPA02000924A (es) | 2003-07-14 |
CA2380208A1 (en) | 2001-02-01 |
EP1204669A1 (en) | 2002-05-15 |
TW559558B (en) | 2003-11-01 |
DK1204669T3 (da) | 2006-02-20 |
ES2252033T3 (es) | 2006-05-16 |
AU775296B2 (en) | 2004-07-29 |
WO2001007453A1 (en) | 2001-02-01 |
CY1105359T1 (el) | 2010-03-03 |
JP2003505465A (ja) | 2003-02-12 |
NZ516783A (en) | 2005-03-24 |
EP1204669B1 (en) | 2005-11-09 |
DE60023910T2 (de) | 2006-07-20 |
US6495523B1 (en) | 2002-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR025444A1 (es) | Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos | |
ES2175161T3 (es) | Derivados de piperazina como antagonistas de taquiquinina. | |
WO2005011655A3 (en) | Pyridazine derivatives and their use as therapeutic agents | |
WO2005011653A3 (en) | Pyridazine derivatives and their use as therapeutic agents | |
AR020662A1 (es) | Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento. | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
AR029175A1 (es) | Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento | |
ES2161290T3 (es) | Derivados de quinazolina. | |
ECSP045483A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso | |
AR033346A1 (es) | Acido aminoalcano carboxilicos, un procedimiento para su preparacion, intermediarios, y el uso de los mismos para la manufactura de un medicamento | |
AR006678A1 (es) | Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion | |
BRPI0409427A (pt) | composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo | |
BRPI0418004A (pt) | composto ou um sal, solvato, solvato de um tal sal ou uma pró-droga deste farmaceuticamente aceitáveis, métodos para tratar ou prevenir condições hiperlipidêmicas, aterosclerose, mal de alzheimer, e tumores associados com colesterol, formulação farmacêutica, combinação, e, processo para preparar um composto ou um sal, solvato, solvato de um tal sal ou uma pró-droga deste farmaceuticamente aceitáveis | |
BR0316690A (pt) | Composto, prodroga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
AR019496A1 (es) | Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos | |
AR010894A1 (es) | Aminoacidos aromaticos biciclicos, un procedimiento para prepararlos, preparaciones farmaceuticas que lo contienen y el empleo de los mismos parapreparar un medicamento que actua como inhibidor de la integrina. | |
UY28356A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos | |
ES2135342B1 (es) | Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama. | |
DE60233276D1 (de) | Verfahren zur Herstellung der Natrium Salze von Retinoylderivaten | |
AR026267A1 (es) | Agentes heterociclicos citotoxicos. | |
DE69824313D1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
UY28357A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos | |
AR030912A1 (es) | Uso de derivados monosacaridos triciclicos y sus sales para preparar un medicamento para prevenir o tratar la neurodegeneracion inducida por isquemia, derivados monosacaridos triciclicos y sales y composiciones farmaceuticas que los comprenden | |
MX9400165A (es) | Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen. | |
DE602004022783D1 (de) | Heterozyklische harnstoff-derivate für die behandlung von schmerzen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |